Darrin Miles Net Worth & Insider Trades
Darrin Miles - Chief Commercial Officer, Agios Pharmaceuticals, Inc
What is Darrin Miles's Net Worth?
The current estimated net worth of Agios Pharmaceuticals, Inc's Chief Commercial Officer, Darrin Miles, is estimated to be about $674.02K . Darrin Miles owns about 7,209 units of Agios Pharmaceuticals, Inc common stock. In the last 3 months at Agios Pharmaceuticals, Inc, Darrin Miles has sold an estimated value of $321.7K worth.
What is Darrin Miles's Past Insider Trading?
Darrin Miles's largest sale order was 3,462 units , worth over $191.83K on May 18, 2021. In total, Darrin Miles has made about 5 transactions over 3 months of their time at Agios Pharmaceuticals, Inc. Darrin Miles usually trades in February, with the busiest year in 2021.
Darrin Miles
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Darrin Miles's' Mailing Address?
- Mailing address is C/o Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 MA
Agios Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Jacqualyn A. Fouse, Ph.D. | 2020 | $746,750 | - | $1,751,340 | $4,593,651 | $509,657 | $10,577 | $7,611,975 |
| Jacqualyn A. Fouse, Ph.D. | 2019 | $664,583 | - | $2,538,474 | $12,875,608 | $424,125 | $105,204 | $16,607,994 |
| Jacqualyn A. Fouse, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Jonathan Biller | 2020 | $500,000 | - | - | - | $258,750 | $10,578 | $769,328 |
| Jonathan Biller | 2019 | $39,583 | $110,000 | $1,008,334 | $2,025,036 | - | $936 | $3,183,889 |
| Jonathan Biller | 2017 | - | - | - | - | - | - | - |
| Christopher Bowden, M.D. | 2020 | $515,007 | - | $618,120 | $1,508,875 | $243,341 | $9,203 | $2,894,546 |
| Christopher Bowden, M.D. | 2019 | $490,539 | - | $915,590 | $1,609,989 | $198,668 | $12,422 | $3,227,208 |
| Christopher Bowden, M.D. | 2018 | $467,141 | - | $641,025 | $1,746,517 | $262,767 | $11,280 | $3,128,730 |
| Bruce Car, Ph.D. | 2020 | $494,318 | - | $833,301 | $1,499,943 | $236,250 | $164,231 | $3,228,043 |
| Bruce Car, Ph.D. | 2019 | - | - | - | - | - | - | - |
| Bruce Car, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Andrew Hirsch | 2020 | $361,234 | - | $618,120 | $1,508,875 | - | $397,893 | $2,886,122 |
| Andrew Hirsch | 2019 | $500,476 | - | $1,923,145 | $1,609,989 | $202,693 | $12,528 | $4,248,831 |
| Andrew Hirsch | 2018 | $471,329 | - | $641,025 | $1,746,517 | $265,123 | $12,864 | $3,136,858 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm
What are Agios Pharmaceuticals, Inc's Past Insider Trades?
Agios Pharmaceuticals, Inc's most recent insider trade came on January 19, 2023 by David Schenkein who sold 20,000 units worth $577.09K . In the last 10 years, insiders at Agios Pharmaceuticals, Inc have sold an estimated value of $170.1M and bought an estimated value of $172.08M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Scott Biller, Chief Scientific Officer, David Schenkein, Director, and John Duncan Higgons, Chief Operating Officer .
AGIOS PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||